Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 17, 2015

View Archived Issues

Novel conjugated vaccine shows greater protection against anthrax in mice

Hanmi initiates phase I trial of weekly-dosing formulation of basal insulin

Serendex to conduct phase II trial of inhaled GM-CSF in pneumonia-associated ARDS

VLPs show efficacy as pandemic avian influenza virus vaccines

BAY-94-9027 prophylaxis based on bleeding phenotype leads to greater control

New Bcl-2 inhibitors disclosed by Servier and Vernalis

Bayer divulges dual BRD4/PLK1 inhibitors

Actelion patents CXCR3 receptor antagonists

Janssen discloses new anti-HBV compounds

Polish and French team discloses 5-HT6 receptor antagonists

Actavis to divest Pharmatech to TPG

PEG-rFVIII shows safety and efficacy in hemophilia A patients

Small-sized Mucosolvan approved in Japan

Hospira launches first biosimilar MAb in major European markets

Galapagos reports promising phase I data for GLPG-1690

Dako and Ono Pharmaceutical to develop companion diagnostic test for Opdivo

Motesanib fails to achieve primary endpoint in phase III trial in NSCLC

FDA awards orphan drug designation to trofinetide for Rett syndrome

Molecular Templates recruits participants in phase I trial of MT-3724

Crown Bioscience acquires patient-derived xenograft models business from Molecular Response

CLS presents PK results of rFIX-albumin fusion protein

Great Basin begins clinical trial for Shiga toxin-producing E. coli diagnostic test

Hyperion Therapeutics enters into DiaPep277 agreements

FDA grants orphan drug status to RPC-4046 for eosinophilic esophagitis

Reolysin receives FDA orphan drug status for pancreatic cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...